Clarus Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Clarus Wealth Advisors's LLY Position: Q2 2025 in Review
Clarus Wealth Advisors sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 1,192 shares — an estimated $898K sold.
Clarus Wealth Advisors first reported a position in LLY in Q2 2018 and held it in 18 quarters. The position peaked at $944K in Q4 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.
- Clarus Wealth Advisors reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
- Clarus Wealth Advisors sold 1,192 Eli Lilly shares in Q2 2025, an estimated $898K.
- Clarus Wealth Advisors first reported a position in Eli Lilly in Q2 2018 and held it in 18 quarters.
- Clarus Wealth Advisors's Eli Lilly position peaked at $944K in Q4 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.
Based on Clarus Wealth Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.